Literature DB >> 32034507

Intrahepatic cholestasis of pregnancy as a risk factor for preeclampsia.

Nissim Arbib1,2, Eran Hadar3,4, Matan Mor1,5, Anat Shmueli1,6, Eyal Krispin1,6, Ron Bardin1,6, Orly Sneh-Arbib1,7, Marius Braun1,7.   

Abstract

PURPOSE: Intrahepatic cholestasis of pregnancy and preeclampsia are two major pregnancy complications. We aimed to investigate the association between intrahepatic cholestasis of pregnancy (ICP) and preeclampsia.
METHODS: Single-center retrospective study. Study group included 180 women (162 singletons and 18 twin gestations) who were diagnosed with ICP based on clinical presentation, elevated liver enzymes and bile acids. The reference group included 1618 women (1507 singletons and 111 twin gestations) who delivered during the study period, and were matched according to age, gravidity, parity and singleton or twin gestation.
RESULTS: The incidence of ICP was 0.36%. The incidence of preeclampsia was higher in women with ICP compared to reference group (7.78% vs 2.41%, aOR, 3.74 95% CI 12.0-7.02, p < 0.0001), for either without-(3.89% vs 1.61%, aOR 2.83, 95% CI 1.23-6.5, p = 0.145) or with severe features (3.89% vs 0.80%, aOR 5.17 95% CI 2.14-12.50, p = 0.0003). For both singleton and twin pregnancies, overall preeclampsia rates were higher in the ICP group (5.56% vs 2.19%, aOR 2.91 95% CI 1.39-6.07 p = 0.0045; and 27.78% vs 5.41%, aOR 10.9 95% CI 2.16-47.19, p = 0.0033, respectively). Earlier diagnosis of ICP was associated with higher incidence of preeclampsia (31.1 ± 3.8 vs 34.86 ± 6.2 gestational weeks, p = 0.0259). The average time between ICP diagnosis and to the onset of preeclampsia was 29.7 ± 24 days.
CONCLUSION: ICP is associated with an increased risk for preeclampsia. We suggest intensified follow-up for preeclampsia in women with ICP, especially among those with early ICP presentation and twins' gestations.

Entities:  

Keywords:  Bile acids; Cholestasis; High risk; Preeclampsia; Pregnancy; Twins

Mesh:

Year:  2020        PMID: 32034507     DOI: 10.1007/s00404-020-05456-y

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  3 in total

1.  Birth weight standards in the live-born population in Israel.

Authors:  Shaul Dollberg; Ziona Haklai; Francis B Mimouni; Iftah Gorfein; Ethel-Sherry Gordon
Journal:  Isr Med Assoc J       Date:  2005-05       Impact factor: 0.892

2.  Maternal lipids, BMI and IL-17/IL-35 imbalance in concurrent gestational diabetes mellitus and preeclampsia.

Authors:  Weiping Cao; Xinzhi Wang; Tingmei Chen; Wenlin Xu; Fan Feng; Songlan Zhao; Zuxian Wang; Yu Hu; Bing Xie
Journal:  Exp Ther Med       Date:  2018-05-10       Impact factor: 2.447

3.  Obstetric cholestasis in Hong Kong--local experience with eight consecutive cases.

Authors:  T K Lo; W L Lau; Helena S W Lam; W C Leung; Robert K H Chin
Journal:  Hong Kong Med J       Date:  2007-10       Impact factor: 2.227

  3 in total
  6 in total

1.  Multivariate logistic regression analysis of preeclampsia in patients with pregnancy induced hypertension and the risk predictive value of monitoring platelet, coagulation function and thyroid hormone in pregnant women.

Authors:  Li Zeng; Chunfang Liao
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

2.  Serum microRNAs as non-invasive diagnostic biomarkers for intrahepatic cholestasis of pregnancy.

Authors:  Yue Zu; Sheng Guo; Guodong Li; Qianyan Gao; Ximin Wang; Chengliang Zhang; Dong Liu
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

3.  Intrahepatic Cholestasis of Pregnancy and Associated Adverse Maternal and Fetal Outcomes: A Retrospective Case-Control Study.

Authors:  Mingjuan Luo; Mengyang Tang; Feng Jiang; Yizhen Jia; Robert Kien Howe Chin; Wei Liang; Hu Cheng
Journal:  Gastroenterol Res Pract       Date:  2021-03-25       Impact factor: 2.260

4.  Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes and preeclampsia.

Authors:  Congcong Liu; Jinsong Gao; Juntao Liu; Xietong Wang; Jing He; Jingxia Sun; Xiaowei Liu; Shixiu Liao
Journal:  Ann Transl Med       Date:  2020-12

5.  Expression Level of IL-17 in Peripheral Blood of Patients with Late Pregnancy and Diagnosis of Maternal-Fetal Tolerance Based on Brain MRI Image Segmentation Algorithm.

Authors:  Zenying Yu; Shengyan Zhou; Zhen Tan; Guangmin Lu
Journal:  Pak J Med Sci       Date:  2021       Impact factor: 1.088

6.  Association of Elevated Maternal Serum Total Bile Acids With Low Birth Weight and Intrauterine Fetal Growth Restriction.

Authors:  Fuzhen Song; Yuanyuan Chen; Lei Chen; Huan Li; Xiajin Cheng; Weibin Wu
Journal:  JAMA Netw Open       Date:  2021-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.